Chemoenzymatically synthesized ganglioside GM3 analogues with inhibitory effects on tumor cell growth and migration

Area of Science:

• Glycosphingolipid chemistry
• Cancer biology
• Drug discovery

Background:

• Ganglioside GM3 is a tumor-associated carbohydrate antigen implicated in cancer development.
• GM3 influences critical processes like cell proliferation, adhesion, and differentiation.
• Understanding GM3's role is key to developing targeted cancer therapies.

Purpose of the Study:

• To synthesize novel mannose-containing GM3 analogues.
• To evaluate the antiproliferative and anti-migration activities of these analogues.
• To explore their potential as antitumor drug leads.

Main Methods:

• Enzymatic hydrolysis and chemical synthesis were used to create novel GM3 analogues.
• Antiproliferative activity was assessed on K562 and HCT116 cancer cell lines.
• Tumor cell migration was evaluated using the wound healing assay on B16, B16-F10, and HCCLM3 cells.

Main Results:

• Synthesized novel mannose-containing GM3 analogues were successfully created.
• The novel analogues, along with previously prepared galactose analogues, demonstrated significant antiproliferative effects.
• The compounds showed an influence on tumor cell migration in various cancer cell lines.

Conclusions:

• Novel GM3 analogues exhibit promising antiproliferative and anti-migration properties.
• These findings provide a foundation for optimizing lead compounds in cancer drug discovery.
• The study offers valuable insights for developing new antitumor agents for cancer therapy.